Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (2), 188-93

A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children With Autism Spectrum Disorders

Affiliations

A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children With Autism Spectrum Disorders

Khaled Saad et al. Clin Psychopharmacol Neurosci.

Abstract

Objective: There is growing evidence for a gut-brain connection associated with autism spectrum disorders (ASDs). This suggests a potential benefit from introduced digestive enzymes for children with ASD.

Methods: We performed a double-blind, randomized clinical trial on 101 children with ASD (82 boys and 19 girls) aged from 3 to 9 years. ASD patients were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders 4th edition, text revision (DSM-IV-TR) diagnostic criteria. Structured interviews of at least one hour each both with the parents and the child were performed. Later on, another two hours-session was conducted applying the Childhood Autism Rating Scale (CARS). ASD patients were randomized to receive digestive enzymes or placebo.

Results: The ASD group receiving digestive enzyme therapy for 3 months had significant improvement in emotional response, general impression autistic score, general behavior and gastrointestinal symptoms. Our study demonstrated the usefulness of digestive enzyme in our population of ASD patients.

Conclusion: Digestive enzymes are inexpensive, readily available, have an excellent safety profile, and have mildly beneficial effects in ASD patients. Depending on the parameter measured in our study, we propose digestive enzymes for managing symptoms of ASD. Digestive enzyme therapy may be a possible option in treatment protocols for ASD in the future.

Keywords: Autism spectrum disorders; Child; Clinical trial; Digestive enzymes.

Similar articles

See all similar articles

Cited by 10 PubMed Central articles

See all "Cited by" articles

References

    1. Munasinghe SA, Oliff C, Finn J, Wray JA. Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial. J Autism Dev Disord. 2010;40:1131–1138. doi: 10.1007/s10803-010-0974-2. - DOI - PubMed
    1. Saad K, Hammad E, Abdel-rahman AA, Sobhy KM. Autistic symptoms in late diagnosed phenylketonuric children in upper Egypt. J Neurol Res. 2013;3:51–55.
    1. Parmeggiani A. Gastrointestinal disorders and autism. In: Patel VB, Preedy VR, Martin CR, editors. Comprehensive guide to autism. New York: Springer Science plus Business Media; 2014. pp. 2035–2046. - DOI
    1. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr. 2011;11:111. doi: 10.1186/1471-2431-11-111. - DOI - PMC - PubMed
    1. Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E. A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat. 2012;2012:870391. - PMC - PubMed
Feedback